Consensus Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
65.19 ^USD	-0.58%		-1.17%	+3.81%

May. 08	Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing	MT

Evolution of the average Target Price on Vaxcyte, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7f3d0edfe490c13d030157f8b.WIFojBi6ISGJj6AkXnqQdaGE-BNsPDibQ1VAiN6Z7M0.HfA5_nTgFnTB6sZpFDnWG8DpvFs7BUnMOhQT6Z3ts-BpzQvIXs9oF7DG4Q~889ff8a204c0d2a2e94b56562ebe7aa1

Analyst Recommendations on Vaxcyte, Inc.

Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing	Apr. 25	MT
Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing	Mar. 21	MT
Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating	Mar. 12	MT
Needham Raises Price Target on Vaxcyte to $95 From $73, Maintains Buy Rating	Feb. 28	MT
Mizuho Initiates Vaxcyte With Buy Rating, Price Target is $69	Dec. 07	MT
TD Cowen Starts Vaxcyte at Outperform	23-04-18	MT
BofA Securities Adjusts Price Target on Vaxcyte to $68 From $63, Keeps Buy Rating	23-04-18	MT
Guggenheim Adjusts Price Target on Vaxcyte to $65 From $66, Maintains Buy Rating	23-02-28	MT
Needham Adjusts Price Target on Vaxcyte to $58 From $52, Maintains Buy Rating	23-01-03	MT
SVB Securities Initiates Vaxcyte With Outperform Rating, Sets Price Target at $60	22-12-16	MT
Guggenheim Initiates Vaxcyte at Buy With $66 Price Target	22-12-15	MT
BTIG Starts Vaxcyte at Buy With $69 Price Target	22-11-17	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

65.19 USD

Average target price

103.1 USD

Spread / Average Target

+58.22%

High Price Target

113 USD

Spread / Highest target

+73.34%

Low Price Target

95 USD

Spread / Lowest Target

+45.73%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Vaxcyte, Inc.

Mizuho Securities
Needham & Co.
TD Cowen
BofA Securities
Guggenheim
SVB Securities LLC
BTIG

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar